Jingyuan Sun
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Antiangiogenic Treatment Facilitates the Abscopal Effect of Radiation Therapy Combined With Anti-PD-1 in Hepatocellular Carcinoma.
Journal: International journal of radiation oncology, biology, physics
Published: April 17, 2024
Polystyrene microplastics aggravate radiation-induced intestinal injury in mice.
Journal: Ecotoxicology and environmental safety
Published: March 21, 2024
Single-cell Transcriptomic Analysis Reveals an Immunosuppressive Network Between POSTN CAFs and ACKR1 ECs in TKI-resistant Lung Cancer.
Journal: Cancer genomics & proteomics
Published: August 21, 2023
Targeting NAD+ metabolism of hepatocellular carcinoma cells by lenvatinib promotes M2 macrophages reverse polarization, suppressing the HCC progression.
Journal: Hepatology international
Published: January 30, 2023
Case report: Abolishing primary resistance to PD-1 blockade by short-term treatment of lenvatinib in a patient with advanced metastatic renal cell carcinoma.
Journal: Frontiers in immunology
Published: December 04, 2022
UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.
Journal: Cell death & disease
Published: March 12, 2021
Wnt/β-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune microenvironment in hepatocellular carcinoma.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 21, 2020
UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 26, 2020
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: April 29, 2020
Chromobox homolog 8 (CBX8) Interacts with Y-Box binding protein 1 (YBX1) to promote cellular proliferation in hepatocellular carcinoma cells.
Journal: Aging
Published: May 18, 2019
Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of β-catenin in hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 20, 2019
Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway.
Journal: Journal of pharmacological sciences
Published: August 18, 2015
Last Updated: 09/26/2026